![Loretta Itri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Loretta Itri
Keine laufenden Positionen mehr
Profil
Loretta M. Itri ist Chief Medical Officer von Immunomedics, Inc. In der Vergangenheit hatte sie die Position des Chief Medical Officer bei Genta, Inc. inne, Senior Vice President-Medical & Regulatory Affairs beim Robert Wood Johnson Pharmaceutical Research Institute, Chief Medical Officer & Senior VP-Clinical Affairs bei Ortho Biotech Products LP, Senior Director-Clinical Investigations bei Hoffmann-La Roche, Inc, EVP-Global Health Science & Regulatory Affairs bei The Medicines Co. und Member-Scientific Counselor beim National Cancer Institute. Dr. Itri erhielt einen Doktortitel vom New York Medical College und einen Bachelor-Abschluss von der Long Island University.
Ehemalige bekannte Positionen von Loretta Itri
| Unternehmen | Position | Ende |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2024 |
| THE MEDICINES COMPANY | General Counsel | 01.05.2019 |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
| PHARMACYCLICS, INC. | Direktor/Vorstandsmitglied | 09.08.2006 |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Ausbildung von Loretta Itri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Genta, Inc.
Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
Ortho Biotech, Inc. | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Provides innovative products and services to help enhance patients health | Health Technology |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Pharmaceutical Research Institute
 Robert Wood Johnson Pharmaceutical Research Institute BiotechnologyHealth Technology Engages in pharmaceutical research and development | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Wählen Sie MarketScreener 
